Kenvue Inc. Tylenol Brand Paallinger for sale in a pharmacy in New York, USA, on Wednesday, March 27, 2024.
Bloomberg | Bloomberg | Getty images
Actions of Kenvue More than 10% fell on Friday after a report that the Secretary of Health and Human Services Robert F. Kennedy Jr. will probably link autism with the use of the company's pain medication in pregnant women.
HHS will publish the report that could extract that link this month, the Wall Street Journal reported on Friday.
This report will also suggest a medication derived from folate, a water soluble vitamin, can be used to treat the symptoms of development disorder in some people, according to the Journal.
In a statement, an HHS spokesman said that “we are using standard gold science to reach the bottom of the unprecedented increase in the United States in autism rates.”
“Until we publish the final report, any statement about its content is nothing more than speculation,” they added.
Tylenol could be the last widely used and accepted treatment that Kennedy has undermined the HHS rudder, which supervises federal health agencies that regulate drugs and other therapies. Kennedy has also taken measures to change vaccine policy in the US., And has amplified false claims about safe and effective shots that use RNM technology.
Kennedy has made the disorder a key approach to HHS, promising in April that the agency “will know what the autism epidemic has caused” in September and eliminates the exhibitions. He also said that month that the agency has launched a “massive effort of evidence and research” that involves hundreds of scientists worldwide who will determine the cause.
In a statement, Kenvue said that “he has continually evaluated science and [continues] To believe that there is no causal link “between the use of acetaminophen, the generic name of Tylenol, during pregnancy and autism.
The company added that the Food and Medicines Administration and the main medical organizations “agree the security” of the medication, its use during pregnancy and the information provided on the Tylenol label.
The FDA website says that the agency has not found “clear evidence” that the appropriate use of acetaminophen during pregnancy causes “adverse pregnancy, birth, neuroconductual or development results.” But the FDA said it advises pregnant women to talk to their medical care suppliers before using free sales drugs.
The American College of Obstetricians and Gynecologists maintains that acetaminophen is safe during pregnancy when taken according to the indications and after consulting a medical care provider.
Some previous studies have suggested that the medicine raises risks to fetal development, and some parents have filed demands claiming that they gave birth to children with autism after using it.
But a federal judge in Manhattan ruled in 2023 that some of these demands lacked scientific evidence and then the litigation ended in 2024. Some investigations have not found association between the use of acetaminophen and autism.
In a note on Friday, BNP Paribas analyst Navann Ty said the firm believes that the “obstacle to testing causality [between the drug and autism] It is high, particularly since the litigation previously concluded in favor of Kenvue. “
– Angelica Peebles de CNBC contributed to this report.
